Clinical records
Studies/Post-marketing surveillance studies
Studies/Post-marketing surveillance studies
Medaxis' debritom⁺ has already been tested and evaluated in some applications in the past. The journal of aesthetic and surgical dermatology, Kammerlander Consulting, as well as Prof. Dr. Luc Téot of Clinical, Nursing and Patient Care monitored the first generation debritom device. The results can be summarized as follows:
- debritom⁺ significantly reduces the time needed for cleaning wounds.
- The instrument can be used by both physicians and other health care professionals.
- The applications with debritom⁺ is relatively painless.
White Paper - Efficacy of weekly debridement
White Paper - Pain and the chronic wound
White Paper - Understanding Biofilm: Treatments & Controversies
White Paper - Best practice debridement and the impact of COVID-19
White Paper - The value of a good debridement
Retrospective clinical application observation of the Obwalden cantonal hospital (2017)
Retrospective clinical application observation of the Obwalden cantonal hospital (2014)
Call for study participation
If you are a physician or wound care professional and are interested in conducting a study, please do not hesitate to contact us.